{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:12:02Z","timestamp":1793157122560,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R400-2022-509"],"award-info":[{"award-number":["R400-2022-509"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R322-2019-1816"],"award-info":[{"award-number":["R322-2019-1816"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R344-2020-106"],"award-info":[{"award-number":["R344-2020-106"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["3102-00006"],"award-info":[{"award-number":["3102-00006"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["R01NS116694"],"award-info":[{"award-number":["R01NS116694"]}]},{"DOI":"10.13039\/100008398","name":"Villum Fonden","doi-asserted-by":"publisher","award":["19063"],"award-info":[{"award-number":["19063"]}],"id":[{"id":"10.13039\/100008398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26820-5","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:24:09Z","timestamp":1764325449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cone snail venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain"],"prefix":"10.1038","volume":"15","author":[{"given":"Walden E.","family":"Bj\u00f8rn-Yoshimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Bea L.","family":"Ramiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Lund","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebbe","family":"Engholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yan","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper K.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine L.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knud J.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Patwardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Safavi-Hemami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"26820_CR1","volume-title":"Hospitalized Chronic Pain Patient: A Multidisciplinary Treatment Guide","author":"MZ Murphy","year":"2022","unstructured":"Murphy, M. Z., Jackson, T. P. & Mishra, P. Hospitalized Chronic Pain Patient: A Multidisciplinary Treatment Guide (Springer, 2022)."},{"key":"26820_CR2","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/s0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen, S. P., Vase, L. & Hooten, W. M. Chronic pain: An update on burden, best practices, and new advances. Lancet 397, 2082\u20132097. https:\/\/doi.org\/10.1016\/s0140-6736(21)00393-7 (2021).","journal-title":"Lancet"},{"key":"26820_CR3","volume-title":"Pain Management Medications","author":"DA Queremel Milani","year":"2023","unstructured":"Queremel Milani, D. A. & Davis, D. D. Pain Management Medications (StatPearls, 2023)."},{"key":"26820_CR4","unstructured":"CDC. Centers for Disease Control and Prevention: Understanding the Opioid Overdose Epidemic (2023). https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html."},{"key":"26820_CR5","doi-asserted-by":"publisher","first-page":"T61","DOI":"10.1530\/jme-13-0274","volume":"52","author":"H Tostivint","year":"2014","unstructured":"Tostivint, H. et al. Molecular evolution of GPCRs: Somatostatin\/urotensin II receptors. J. Mol. Endocrinol. 52, T61-86. https:\/\/doi.org\/10.1530\/jme-13-0274 (2014).","journal-title":"J. Mol. Endocrinol."},{"key":"26820_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0005-2736(03)00235-9","volume":"1616","author":"LN M\u00f8ller","year":"2003","unstructured":"M\u00f8ller, L. N., Stidsen, C. E., Hartmann, B. & Holst, J. J. Somatostatin receptors. Biochem. Biophys. Acta 1616, 1\u201384. https:\/\/doi.org\/10.1016\/s0005-2736(03)00235-9 (2003).","journal-title":"Biochem. Biophys. Acta"},{"key":"26820_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.tem.2013.11.003","volume":"25","author":"M Chalabi","year":"2014","unstructured":"Chalabi, M. et al. Somatostatin analogs: Does pharmacology impact antitumor efficacy?. Trends Endocrinol. Metab. 25, 115\u2013127. https:\/\/doi.org\/10.1016\/j.tem.2013.11.003 (2014).","journal-title":"Trends Endocrinol. Metab."},{"key":"26820_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1210\/er.2000-0001","volume":"24","author":"LJ Hofland","year":"2003","unstructured":"Hofland, L. J. & Lamberts, S. W. The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr. Rev. 24, 28\u201347. https:\/\/doi.org\/10.1210\/er.2000-0001 (2003).","journal-title":"Endocr. Rev."},{"key":"26820_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0026-0495(92)90023-4","volume":"41","author":"J Pless","year":"1992","unstructured":"Pless, J. From somatostatin to Sandostatin\u00ae: History and chemistry. Metabolism 41, 5\u20136. https:\/\/doi.org\/10.1016\/0026-0495(92)90023-4 (1992).","journal-title":"Metabolism"},{"key":"26820_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ejphar.2007.09.033","volume":"578","author":"K Elekes","year":"2008","unstructured":"Elekes, K. et al. Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse. Eur. J. Pharmacol. 578, 313\u2013322. https:\/\/doi.org\/10.1016\/j.ejphar.2007.09.033 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"26820_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.pharmthera.2006.04.010","volume":"112","author":"E Pinter","year":"2006","unstructured":"Pinter, E., Helyes, Z. & Szolcsanyi, J. Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol. Ther. 112, 440\u2013456. https:\/\/doi.org\/10.1016\/j.pharmthera.2006.04.010 (2006).","journal-title":"Pharmacol. Ther."},{"key":"26820_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2004.07.085","volume":"498","author":"J Szolcsanyi","year":"2004","unstructured":"Szolcsanyi, J. et al. Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia. Eur. J. Pharmacol. 498, 103\u2013109. https:\/\/doi.org\/10.1016\/j.ejphar.2004.07.085 (2004).","journal-title":"Eur. J. Pharmacol."},{"key":"26820_CR13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1124\/jpet.105.094128","volume":"316","author":"M Engstr\u00f6m","year":"2006","unstructured":"Engstr\u00f6m, M., Savola, J. M. & Wurster, S. Differential efficacies of somatostatin receptor agonists for G-protein activation and desensitization of somatostatin receptor subtype 4-mediated responses. J. Pharmacol. Exp. Ther. 316, 1262\u20131268. https:\/\/doi.org\/10.1124\/jpet.105.094128 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"26820_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2006.03.082","volume":"539","author":"K S\u00e1ndor","year":"2006","unstructured":"S\u00e1ndor, K. et al. Analgesic effects of the somatostatin sst4 receptor selective agonist J-2156 in acute and chronic pain models. Eur. J. Pharmacol. 539, 71\u201375. https:\/\/doi.org\/10.1016\/j.ejphar.2006.03.082 (2006).","journal-title":"Eur. J. Pharmacol."},{"key":"26820_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neulet.2014.04.042","volume":"573","author":"L Gorham","year":"2014","unstructured":"Gorham, L., Just, S. & Doods, H. Somatostatin 4 receptor activation modulates TRPV1[correction of TPRV1] currents in dorsal root ganglion neurons. Neurosci. Lett. 573, 35\u201339. https:\/\/doi.org\/10.1016\/j.neulet.2014.04.042 (2014).","journal-title":"Neurosci. Lett."},{"key":"26820_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abk1410","volume":"8","author":"IBL Ramiro","year":"2022","unstructured":"Ramiro, I. B. L. et al. Somatostatin venom analogs evolved by fish-hunting cone snails: From prey capture behavior to identifying drug leads. Sci. Adv. 8, eabk1410. https:\/\/doi.org\/10.1126\/sciadv.abk1410 (2022).","journal-title":"Sci. Adv."},{"key":"26820_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msac075","volume":"39","author":"TL Koch","year":"2022","unstructured":"Koch, T. L. et al. Reconstructing the origins of the somatostatin and allatostatin-C signaling systems using the accelerated evolution of biodiverse cone snail venoms. Mol. Biol. Evol. 39, msac075. https:\/\/doi.org\/10.1093\/molbev\/msac075 (2022).","journal-title":"Mol. Biol. Evol."},{"key":"26820_CR18","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/nprot.2013.084","volume":"8","author":"BJ Haas","year":"2013","unstructured":"Haas, B. J. et al. De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis. Nat. Protoc. 8, 1494\u20131512. https:\/\/doi.org\/10.1038\/nprot.2013.084 (2013).","journal-title":"Nat. Protoc."},{"key":"26820_CR19","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V. & Thirion, B. Scikit-learn: Machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"26820_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nsmb.3014","volume":"22","author":"WK Kroeze","year":"2015","unstructured":"Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362\u2013369. https:\/\/doi.org\/10.1038\/nsmb.3014 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"26820_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-4939-2914-6_8","volume":"1335","author":"I Masuho","year":"2015","unstructured":"Masuho, I., Martemyanov, K. A. & Lambert, N. A. Monitoring G protein activation in cells with BRET. Methods Mol. Biol. 1335, 107\u2013113. https:\/\/doi.org\/10.1007\/978-1-4939-2914-6_8 (2015).","journal-title":"Methods Mol. Biol."},{"key":"26820_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atc.2004.11.009","volume":"23","author":"TJ Brennan","year":"2005","unstructured":"Brennan, T. J., Zahn, P. K. & Pogatzki-Zahn, E. M. Mechanisms of incisional pain. Anesthesiol. Clin. N. Am. 23, 1\u201320. https:\/\/doi.org\/10.1016\/j.atc.2004.11.009 (2005).","journal-title":"Anesthesiol. Clin. N. Am."},{"key":"26820_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M. & Yaksh, T. L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55\u201363. https:\/\/doi.org\/10.1016\/0165-0270(94)90144-9 (1994).","journal-title":"J. Neurosci. Methods"},{"key":"26820_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41422-022-00679-x","volume":"32","author":"W Zhao","year":"2022","unstructured":"Zhao, W. et al. Structural insights into ligand recognition and selectivity of somatostatin receptors. Cell Res. 32, 761\u2013772. https:\/\/doi.org\/10.1038\/s41422-022-00679-x (2022).","journal-title":"Cell Res."},{"key":"26820_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132, 19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001 (2015).","journal-title":"SoftwareX"},{"key":"26820_CR26","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. J. Chem. Theory Comput. 8, 3257\u20133273. https:\/\/doi.org\/10.1021\/ct300400x (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"26820_CR27","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1021\/ct200328p","volume":"7","author":"O Guvench","year":"2011","unstructured":"Guvench, O. et al. CHARMM additive all-atom force field for carbohydrate derivatives and its utility in polysaccharide and carbohydrate-protein modeling. J. Chem. Theory Comput. 7, 3162\u20133180. https:\/\/doi.org\/10.1021\/ct200328p (2011).","journal-title":"J. Chem. Theory Comput."},{"key":"26820_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1021\/ct700200b","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess, B. P-LINCS: A parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 4, 116\u2013122. https:\/\/doi.org\/10.1021\/ct700200b (2008).","journal-title":"J. Chem. Theory Comput."},{"key":"26820_CR29","doi-asserted-by":"publisher","first-page":"6408","DOI":"10.1038\/s41467-024-50470-2","volume":"15","author":"HY Yeung","year":"2024","unstructured":"Yeung, H. Y. et al. Fish-hunting cone snail disrupts prey\u2019s glucose homeostasis with weaponized mimetics of somatostatin and insulin. Nat. Commun. 15, 6408. https:\/\/doi.org\/10.1038\/s41467-024-50470-2 (2024).","journal-title":"Nat. Commun."},{"key":"26820_CR30","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s00018-005-5283-0","volume":"62","author":"O Buczek","year":"2005","unstructured":"Buczek, O., Bulaj, G. & Olivera, B. M. Conotoxins and the posttranslational modification of secreted gene products. Cell. Mol. Life Sci. CMLS 62, 3067\u20133079. https:\/\/doi.org\/10.1007\/s00018-005-5283-0 (2005).","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"26820_CR31","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/j.pain.0000000000001217","volume":"159","author":"P Ray","year":"2018","unstructured":"Ray, P. et al. Comparative transcriptome profiling of the human and mouse dorsal root ganglia: An RNA-seq\u2013based resource for pain and sensory neuroscience research. Pain 159, 1325\u20131345. https:\/\/doi.org\/10.1097\/j.pain.0000000000001217 (2018).","journal-title":"Pain"},{"key":"26820_CR32","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3140","volume":"9","author":"AM Cowie","year":"2019","unstructured":"Cowie, A. M. & Stucky, C. L. A mouse model of postoperative pain. Bio Protoc. 9, e3140. https:\/\/doi.org\/10.21769\/BioProtoc.3140 (2019).","journal-title":"Bio Protoc."},{"key":"26820_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00495","volume":"9","author":"PA Shenoy","year":"2018","unstructured":"Shenoy, P. A. et al. The somatostatin receptor-4 agonist J-2156 alleviates mechanical hypersensitivity in a rat model of breast cancer induced bone pain. Front. Pharmacol. 9, 495. https:\/\/doi.org\/10.3389\/fphar.2018.00495 (2018).","journal-title":"Front. Pharmacol."},{"key":"26820_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246245","volume":"20","author":"B K\u00e1nt\u00e1s","year":"2019","unstructured":"K\u00e1nt\u00e1s, B. et al. Novel drug-like somatostatin receptor 4 agonists are potential analgesics for neuropathic pain. Int. J. Mol. Sci. 20, 6245. https:\/\/doi.org\/10.3390\/ijms20246245 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"26820_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108198","volume":"178","author":"\u00c9 Sz\u0151ke","year":"2020","unstructured":"Sz\u0151ke, \u00c9. et al. Small molecule somatostatin receptor subtype 4 (sst4) agonists are novel anti-inflammatory and analgesic drug candidates. Neuropharmacology 178, 108198. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108198 (2020).","journal-title":"Neuropharmacology"},{"key":"26820_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","volume":"96","author":"SH Sindrup","year":"2005","unstructured":"Sindrup, S. H., Otto, M., Finnerup, N. B. & Jensen, T. S. Antidepressants in the treatment of neuropathic pain. Basic Clin. Pharmacol. Toxicol. 96, 399\u2013409. https:\/\/doi.org\/10.1111\/j.1742-7843.2005.pto_96696601.x (2005).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"26820_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/JEP.S124391","volume":"9","author":"GC Quintero","year":"2017","unstructured":"Quintero, G. C. Review about gabapentin misuse, interactions, contraindications and side effects. J. Exp. Pharmacol. 9, 13\u201321. https:\/\/doi.org\/10.2147\/JEP.S124391 (2017).","journal-title":"J. Exp. Pharmacol."},{"key":"26820_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpain.2020.00001","volume":"1","author":"M van Velzen","year":"2020","unstructured":"van Velzen, M., Dahan, A. & Niesters, M. Neuropathic pain: Challenges and opportunities. Front. Pain Res. 1, 1. https:\/\/doi.org\/10.3389\/fpain.2020.00001 (2020).","journal-title":"Front. Pain Res."},{"key":"26820_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","volume":"36","author":"V Isberg","year":"2015","unstructured":"Isberg, V. et al. Generic GPCR residue numbers\u2014Aligning topology maps while minding the gaps. Trends Pharmacol. Sci. 36, 22\u201331. https:\/\/doi.org\/10.1016\/j.tips.2014.11.001 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"26820_CR40","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.4071055","volume":"230","author":"BM Olivera","year":"1985","unstructured":"Olivera, B. M. et al. Peptide neurotoxins from fish-hunting cone snails. Science 230, 1338\u20131343. https:\/\/doi.org\/10.1126\/science.4071055 (1985).","journal-title":"Science"},{"key":"26820_CR41","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.2174\/0929867043363884","volume":"11","author":"GP Miljanich","year":"2004","unstructured":"Miljanich, G. P. Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain. Curr. Med. Chem. 11, 3029\u20133040. https:\/\/doi.org\/10.2174\/0929867043363884 (2004).","journal-title":"Curr. Med. Chem."},{"key":"26820_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jprot.2018.05.009","volume":"190","author":"H Safavi-Hemami","year":"2019","unstructured":"Safavi-Hemami, H., Brogan, S. E. & Olivera, B. M. Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways. J. Proteom. 190, 12\u201320. https:\/\/doi.org\/10.1016\/j.jprot.2018.05.009 (2019).","journal-title":"J. Proteom."},{"key":"26820_CR43","doi-asserted-by":"publisher","first-page":"16019","DOI":"10.1021\/bi981690a","volume":"37","author":"AG Craig","year":"1998","unstructured":"Craig, A. G. et al. An O-glycosylated neuroexcitatory conus peptide. Biochemistry 37, 16019\u201316025. https:\/\/doi.org\/10.1021\/bi981690a (1998).","journal-title":"Biochemistry"},{"key":"26820_CR44","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1097\/j.pain.0000000000002561","volume":"163","author":"L Martin","year":"2022","unstructured":"Martin, L. et al. Conotoxin contulakin-G engages a neurotensin receptor 2\/R-type calcium channel (Cav2.3) pathway to mediate spinal antinociception. Pain 163, 1751\u20131762. https:\/\/doi.org\/10.1097\/j.pain.0000000000002561 (2022).","journal-title":"Pain"},{"key":"26820_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ympev.2014.05.023","volume":"78","author":"N Puillandre","year":"2014","unstructured":"Puillandre, N. et al. Molecular phylogeny and evolution of the cone snails (Gastropoda, Conoidea). Mol. Phylogenet. Evol. 78, 290\u2013303. https:\/\/doi.org\/10.1016\/j.ympev.2014.05.023 (2014).","journal-title":"Mol. Phylogenet. Evol."},{"key":"26820_CR46","first-page":"22","volume":"33","author":"BM Olivera","year":"2021","unstructured":"Olivera, B. M., Watkins, M., Puillandre, N. & Tenorio, M. J. Hidden diversity in the Asprella clade: description of Conus (Asprella) neocostatus sp. Nov. (Gastropoda, Conidae). Xenophora Taxon. 33, 22\u201329 (2021).","journal-title":"Xenophora Taxon."},{"key":"26820_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41594-022-00727-5","volume":"29","author":"MJ Robertson","year":"2022","unstructured":"Robertson, M. J., Meyerowitz, J. G., Panova, O., Borrelli, K. & Skiniotis, G. Plasticity in ligand recognition at somatostatin receptors. Nat. Struct. Mol. Biol. 29, 210\u2013217. https:\/\/doi.org\/10.1038\/s41594-022-00727-5 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"26820_CR48","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1124\/jpet.104.075531","volume":"312","author":"M Engstr\u00f6m","year":"2005","unstructured":"Engstr\u00f6m, M. et al. Superagonism at the human somatostatin receptor subtype 4. J. Pharmacol. Exp. Ther. 312, 332\u2013338. https:\/\/doi.org\/10.1124\/jpet.104.075531 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"26820_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ejphar.2014.11.003","volume":"746","author":"N Schuelert","year":"2015","unstructured":"Schuelert, N. et al. The somatostatin receptor 4 agonist J-2156 reduces mechanosensitivity of peripheral nerve afferents and spinal neurons in an inflammatory pain model. Eur. J. Pharmacol. 746, 274\u2013281. https:\/\/doi.org\/10.1016\/j.ejphar.2014.11.003 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"26820_CR50","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2005.030.06.911225","volume":"30","author":"Z Helyes","year":"2005","unstructured":"Helyes, Z., Pinter, E. & Szolcsanyi, J. TT-232. Drugs Future 30, 0558 (2005).","journal-title":"Drugs Future"},{"key":"26820_CR51","doi-asserted-by":"publisher","DOI":"10.4155\/fdd-2022-0005","volume":"4","author":"C Lamers","year":"2022","unstructured":"Lamers, C. Overcoming the shortcomings of peptide-based therapeutics. Future Drug Discov. 4, FDD75. https:\/\/doi.org\/10.4155\/fdd-2022-0005 (2022).","journal-title":"Future Drug Discov."},{"key":"26820_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jcpt.12404","volume":"41","author":"A Albert-Vartanian","year":"2016","unstructured":"Albert-Vartanian, A. et al. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?. J. Clin. Pharm. Ther. 41, 371\u2013382. https:\/\/doi.org\/10.1111\/jcpt.12404 (2016).","journal-title":"J. Clin. Pharm. Ther."},{"key":"26820_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41573-022-00529-w","volume":"22","author":"P Kurtzhals","year":"2023","unstructured":"Kurtzhals, P., \u00d8stergaard, S., Nishimura, E. & Kjeldsen, T. Derivatization with fatty acids in peptide and protein drug discovery. Nat. Rev. Drug Discov. 22, 59\u201380 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"26820_CR54","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler, M., King, G. F., Adams, D. J. & Alewood, P. F. Trends in peptide drug discovery. Nat. Rev. Drug Discov. 20, 309\u2013325. https:\/\/doi.org\/10.1038\/s41573-020-00135-8 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"26820_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Therapeutic peptides: Current applications and future directions. Signal Transduct. Target. Ther. 7, 48. https:\/\/doi.org\/10.1038\/s41392-022-00904-4 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"26820_CR56","doi-asserted-by":"publisher","first-page":"236","DOI":"10.17085\/apm.2016.11.3.236","volume":"11","author":"S Kang","year":"2016","unstructured":"Kang, S. & Brennan, T. J. Mechanisms of postoperative pain. Anesth. Pain Med. 11, 236\u2013248. https:\/\/doi.org\/10.17085\/apm.2016.11.3.236 (2016).","journal-title":"Anesth. Pain Med."},{"key":"26820_CR57","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1369\/jhc.2009.953919","volume":"57","author":"Z Varecza","year":"2009","unstructured":"Varecza, Z. et al. Expression of the somatostatin receptor subtype 4 in intact and inflamed pulmonary tissues. J. Histochem. Cytochem. 57, 1127\u20131137. https:\/\/doi.org\/10.1369\/jhc.2009.953919 (2009).","journal-title":"J. Histochem. Cytochem."},{"key":"26820_CR58","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.bjp.0706876","volume":"149","author":"Z Helyes","year":"2006","unstructured":"Helyes, Z. et al. Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents. Br. J. Pharmacol. 149, 405\u2013415. https:\/\/doi.org\/10.1038\/sj.bjp.0706876 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"26820_CR59","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s11064-021-03482-z","volume":"47","author":"A Silwal","year":"2022","unstructured":"Silwal, A. et al. Novel somatostatin receptor-4 agonist SM-I-26 mitigates lipopolysaccharide-induced inflammatory gene expression in microglia. Neurochem. Res. 47, 768\u2013780. https:\/\/doi.org\/10.1007\/s11064-021-03482-z (2022).","journal-title":"Neurochem. Res."},{"key":"26820_CR60","unstructured":"ClinicalTrials.gov. NCT04707157 (2023). https:\/\/clinicaltrials.gov\/study\/NCT04707157?term=NCT04707157&rank=1."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26820-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:24:11Z","timestamp":1764325451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26820-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26820-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WEB, IBLR, TLK, and HSH are inventors of a patent application for Fj1 and its analogs (patent application # WO2023180125A1) and WEB and HSH are co-founders of a company focused on the development of novel SSTR4-targeting pain therapeutics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42638"}}